H. Ardila-osorio et al., Evidence of LMP1-TRAF3 interactions in glycosphingolipid-rich complexes oflymphoblastoid and nasopharyngeal carcinoma cells, INT J CANC, 81(4), 1999, pp. 645-649
Latent membrane protein I (LMPI) is an Epstein-Barr virus (EBV) protein exp
ressed in EBV-transformed B lymphocytes and in approximately 50% of nasopha
ryngeal carcinomas (NPCs). LMP I signaling involves several cellular signal
ing intermediates, especially TNF receptor-associated factors (TRAFs). We h
ave shown previously that LMPI is highly concentrated in a cell fraction ca
lled glycosphingolipid-rich membrane complexes (GSL complexes). We report h
ere that parallel accumulation of LMPI and TRAF3, but not TRAF1 or TRADD, w
as observed in GSL complexes from lymphoblastoid and LMPI-positive NPC cell
s. In contrast, TRAF3 was not concentrated in GSL complexes from LMPI-negat
ive cells. Binding of LMPI and TRAF3 in GSL complexes was demonstrated in l
ymphoblastoid and NPC cells, by co-immunoprecipitation with both anti-LMPI
and anti-TRAF3 antibodies. (C) 1999 Wiley-Liss, Inc.